The first patient has been dosed in the phase 3 TERZO trial of Copiktra for relapsed or refractory nodal T-follicular helper ...

Silicon Valley has a grand vision of AI replacing doctors. But this story isn’t about that. Instead, it’s a story about ...

The hematology diagnostics market plays a crucial role in the healthcare industry by providing essential tools for analyzing blood components, diagnosing blood-related disorders, and monitoring ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

A Gilead Sciences-backed therapy made with a patient's own white blood cells shrank tumors in 62% of patients with recurrent ...

WILSON ZOLLA has explained his diagnosis so many times that he sounds like a healthcare provider. Zolla, a senior captain for the Central/West co-op baseball team, has chronic myeloid leukemia (CML), ...

It's essential to understand that this study does not state or imply that energy drinks and supplements will cause cancer in ...

CAR T cell immunotherapy, which uses a patient's own modified immune cells to find and destroy cancer cells, can produce ...

Scientists estimate only around 300 Australians will be diagnosed with Mantle Cell lymphoma in any given year. Unlike many ...

Medically reviewed by Archana Sharma, DO Acute myelogenous leukemia (AML), also known as acute myeloid leukemia, is a type of cancer that starts in your bone marrow (the soft, spongy tissue inside the ...

Instead of producing healthy, functional white blood cells, your bone marrow gets ... the genetic and cellular characteristics of the leukemia cells. This classification system helps doctors ...

In this single-arm trial, the median overall survival (OS) observed was 4.0 months (95% CI: 2.5-7.2) among all 64 adults in the primary efficacy analysis based on the Kaplan-Meier estimate. The median ...